IRLAB A
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
IRLAB Therapeutics is a Swedish research and pharmaceutical company. The research is based on the company's own research platform and specializes in the treatment of brain diseases, commonly referred to as neurodegenerative diseases. At the present, the company holds drug candidates specializing in, among other things, Parkinson's disease. The head office is located in Gothenburg.
Læs mereDelårsrapport Q3'26
Årsrapport '26
Omsætning mio.
EBIT-% (adj.)
EPS (adj.)
Udbytte %
Gå ikke glip af noget - opret en konto og få alle de mulige fordele